Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nikitina

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|September 23, 2023
CLINICAL FEATURES OF CONNECTIVE TISSUE DYSPLASIA, OSGOOD-SCHLATTER DISEASE AND MULTIPLE CORTICAL DISORDERS IN A CHILDMykhailo D Protsailo, Olga Ye Fedortsiv, Volodymyr G Dzhyvak, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|September 4, 2024
Changes in lipid profile parameters depending on the a1166c polymorphism of the angiotensin II type I receptor gene as a predictor of arterial hypertensionVolodymyr V Shmanko, Svitlana R Pidruchna, Roman V Hnizdyukh, et al.
International Journal of Molecular Sciences|January 11, 2025
Innovative Therapies Targeting Drug-Resistant Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma (ccRCC)Moses Owoicho Abah, Deborah Oganya Ogenyi, Angelina V Zhilenkova, et al.
International Journal of Molecular Sciences|July 12, 2025
Comparative Transcriptomics Study of Curcumin and Conventional Therapies in Translocation, Clear Cell, and Papillary Renal Cell Carcinoma SubtypesMoses Owoicho Abah, Deborah Oganya Ogenyi, Angelina V Zhilenkova, et al.
European Journal of Gynaecological Oncology|November 16, 2005
Factors predicting persistence of high-risk human papillomavirus (HPV) infections in women prospectively followed-up in three New Independent States (NIS) of the former Soviet UnionS Syrjänen, I Shabalova, N Petrovichev, et al.
European Journal of Gynaecological Oncology|May 8, 2008
Epidemiological, clinical and viral determinants of the increased prevalence of high-risk human papillomavirus (HPV) infections in elderly womenK Syrjänen, S M Kulmala, I Shabalova, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 6, 2005
Clearance of high-risk human papillomavirus (HPV) DNA and PAP smear abnormalities in a cohort of women subjected to HPV screening in the New Independent States of the former Soviet Union (the NIS cohort study)S Syrjänen, I P Shabalova, N Petrovichev, et al.
Kardiologiia|January 25, 2021
[International register "Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients (ACTIV SARS-CoV-2)"]G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.
Terapevticheskii Arkhiv|October 26, 2022
[ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis]G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.
Kardiologiia|October 29, 2021
Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)E I Tarlovskaya, A G Arutyunov, A O Konradi, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|September 23, 2023
CLINICAL FEATURES OF CONNECTIVE TISSUE DYSPLASIA, OSGOOD-SCHLATTER DISEASE AND MULTIPLE CORTICAL DISORDERS IN A CHILDMykhailo D Protsailo, Olga Ye Fedortsiv, Volodymyr G Dzhyvak, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|September 4, 2024
Changes in lipid profile parameters depending on the a1166c polymorphism of the angiotensin II type I receptor gene as a predictor of arterial hypertensionVolodymyr V Shmanko, Svitlana R Pidruchna, Roman V Hnizdyukh, et al.
International Journal of Molecular Sciences|January 11, 2025
Innovative Therapies Targeting Drug-Resistant Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma (ccRCC)Moses Owoicho Abah, Deborah Oganya Ogenyi, Angelina V Zhilenkova, et al.
International Journal of Molecular Sciences|July 12, 2025
Comparative Transcriptomics Study of Curcumin and Conventional Therapies in Translocation, Clear Cell, and Papillary Renal Cell Carcinoma SubtypesMoses Owoicho Abah, Deborah Oganya Ogenyi, Angelina V Zhilenkova, et al.
European Journal of Gynaecological Oncology|November 16, 2005
Factors predicting persistence of high-risk human papillomavirus (HPV) infections in women prospectively followed-up in three New Independent States (NIS) of the former Soviet UnionS Syrjänen, I Shabalova, N Petrovichev, et al.
European Journal of Gynaecological Oncology|May 8, 2008
Epidemiological, clinical and viral determinants of the increased prevalence of high-risk human papillomavirus (HPV) infections in elderly womenK Syrjänen, S M Kulmala, I Shabalova, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 6, 2005
Clearance of high-risk human papillomavirus (HPV) DNA and PAP smear abnormalities in a cohort of women subjected to HPV screening in the New Independent States of the former Soviet Union (the NIS cohort study)S Syrjänen, I P Shabalova, N Petrovichev, et al.
Kardiologiia|January 25, 2021
[International register "Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients (ACTIV SARS-CoV-2)"]G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.
Terapevticheskii Arkhiv|October 26, 2022
[ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis]G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.
Kardiologiia|October 29, 2021
Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)E I Tarlovskaya, A G Arutyunov, A O Konradi, et al.
Pageof 12